| Year |
Title |
Altmetric |
| 2020
|
Less Toxic Chemotherapy in Locally Advanced Breast Cancer.
Southern Medical Journal.
113:559-563.
2020
|
|
| 2018
|
Tumor and serum DNA methylation in women receiving preoperative chemotherapy with or without vorinostat in TBCRC008.
Breast Cancer Research and Treatment.
167:107-116.
2018
|
|
| 2015
|
TBCRC 008: Early change in 18F-FDG uptake on PET predicts response to preoperative systemic therapy in human epidermal growth factor receptor 2-negative primary operable breast cancer.
Journal of Nuclear Medicine.
56:31-37.
2015
|
|
| 2014
|
How do i recommend extended adjuvant hormonal therapy?.
Current Treatment Options in Oncology.
15:55-62.
2014
|
|
| 2014
|
TBCRC 018: Phase II study of iniparib in combination with irinotecan to treat progressive triple negative breast cancer brain metastases.
Breast Cancer Research and Treatment.
146:557-566.
2014
|
|
| 2012
|
Pathologic complete response predicts recurrence-free survival more effectively by cancer subset: Results from the I-SPY 1 TRIAL - CALGB 150007/150012, ACRIN 6657.
Journal of Clinical Oncology.
30:3242-3249.
2012
|
|
| 2012
|
Chemotherapy response and recurrence-free survival in Neoadjuvant breast cancer depends on biomarker profiles: Results from the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657).
Breast Cancer Research and Treatment.
132:1049-1062.
2012
|
|
| 2011
|
An update on the dosimetric analysis of concurrent radiation therapy and trastuzumab on early cardiac events..
Journal of Clinical Oncology.
29:121.
2011
|
|
| 2011
|
Long-term follow-up of dose-dense neoadjuvant chemotherapy in patients with stage II/III breast cancer..
Journal of Clinical Oncology.
29:e11048.
2011
|
|
| 2010
|
Pilot trial of preoperative (Neoadjuvant) letrozole in combination with bevacizumab in postmenopausal women with newly diagnosed estrogen receptor-or progesterone receptor-positive breast cancer.
Clinical Breast Cancer.
10:275-280.
2010
|
|
| 2006
|
Safety and effectiveness of dose dense neoadjuvant chemotherapy in patients with stage II/III breast cancer..
Journal of Clinical Oncology.
24:10622.
2006
|
|
| 1998
|
Decreased dihydropyrimidine dehydrogenase activity in a population of patients with breast cancer: Implication for 5-fluorouracil-based chemotherapy.
Clinical Cancer Research.
4:325-329.
1998
|
|
| 1995
|
The use of anthracyclines in the adjuvant treatment of breast cancer..
Cancer Treatment Reviews.
21:199-214.
1995
|
|
| 1992
|
Postsurgical adjuvant chemotherapy with or without radiotherapy in women with breast cancer and positive axillary nodes: a South-Eastern Cancer Study Group (SEG) trial.
European Journal of Cancer.
28:1833-1837.
1992
|
|
| 1991
|
Epithelioid hemangioendothelioma: Ct manifestations and possible linkage to vinyl chloride exposure
1991
|
|
| 1991
|
Severe 5‐fluorouracil toxicity secondary to dihydropyrimidine dehydrogenase deficiency. A potentially more common pharmacogenetic syndrome.
Cancer.
68:499-501.
1991
|
|
| 1991
|
Weight gain with breast cancer adjuvant treatment.
Cancer.
67:1954-1959.
1991
|
|
| 1988
|
The pathogenesis and clinical significance of cytologically detectable oral Candida in acute leukemia..
Cancer.
62:2042-2046.
1988
|
|
| 1988
|
Phase I-II study of cisplatin, VP-16, MGBG, mitomycin, and vinblastine with radiation therapy for non-small-cell lung cancer.
1988
|
|
| 1988
|
A randomized comparison of haloperidol plus dexamethasone versus prochlorperazine plus dexamethasone in preventing nausea and vomiting in patients receiving chemotherapy for breast cancer.
Journal of Clinical Oncology.
6:1397-1400.
1988
|
|
| 1988
|
Familial deficiency of dihydropyrimidine dehydrogenase. Biochemical basis for familial pyrimidinemia and severe 5-fluorouracil-induced toxicity.
Journal of Clinical Investigation.
81:47-51.
1988
|
|
| 1988
|
In Reply.
JAMA Surgery.
123:914.
1988
|
|
| 1987
|
Does Radical Mastectomy Still Have a Place in the Treatment of Primary Operable Breast Cancer?.
JAMA Surgery.
122:1317-1320.
1987
|
|
| 1986
|
Phase II trial of diaziquone in anthracycline-resistant adult soft tissue and bone sarcoma patients: A Southeastern Cancer Study Group trial
1986
|
|
| 1986
|
Megestrol acetate v tamoxifen in advanced breast cancer: Correlation of hormone receptors and response.
Seminars in Oncology.
13:9-14.
1986
|
|
| 1986
|
Phase II evaluation of bolus gallium nitrate in lymphoproliferative disorders: A Southeastern Cancer Study Group trial
1986
|
|
| 1985
|
Intrarenal chloroma causing obstructive nephropathy: CT characteristics
1985
|
|
| 1985
|
Metastatic breast cancer: Preliminary results with oral hormonal therapy.
Seminars in Oncology.
12:61-64.
1985
|
|
| 1984
|
Methods of nutritional support for hospitalized patients.
American Family Physician.
29:215-220.
1984
|
|
| 1984
|
Randomized trial of cyclophosphamide, doxorubicin, and 5-fluorouracil alone or alternating with a 'cycle active' non-cross-resistant combination in women with visceral metastatic breast cancer: A Southeastern Cancer Study Group project.
Journal of Clinical Oncology.
2:643-651.
1984
|
|
| 1983
|
A comparison of cyclophosphamide, adriamycin, and 5-fluorouracil (CAF) and cyclophosphamide, methotrexate, 5-fluorouracil, vincristine, and prednisone (CMFVP) in patients with advanced breast cancer - A Southeastern Cancer Study Group Project.
Breast Cancer Research and Treatment.
3:209-220.
1983
|
|
| 1983
|
A randomized prospective trial of radical (Halsted) mastectomy versus modified radical mastectomy in 311 breast cancer patients.
Annals of Surgery.
198:207-212.
1983
|
|
| 1983
|
Southeastern cancer study group: Breast cancer studies 1972-1982
1983
|
|
| 1981
|
The importance of leukopenia in breast cancer adjuvant therapy with melphalan (MPL)
1981
|
|
| 1979
|
Splenectomy for hematologic disease.
Journal of the American College of Surgeons.
149:509-512.
1979
|
|
| 1979
|
A consultant-extender system for breast cancer adjuvant chemotherapy.
ACP journal club.
90:396-401.
1979
|
|
| 1978
|
Agranulocytosis Associated With Disopyramide Therapy.
Journal of the American Medical Association.
240:1857-1858.
1978
|
|
| 1977
|
A comparison of cyclophosphamide, adriamycin, 5‐fluorouracil (CAF) and cyclophosphamide, methotrexate, 5‐fluorouracil, vincristine, prednisone (CMFVP) in patients with metastatic breast cancer. A southeastern cancer study group project.
Cancer.
40:625-632.
1977
|
|
| 1974
|
Central nervous system complications after combination treatment with adriamycin (NSC 123127) and 5 (3,3 dimethyl 1 triazeno)imidazole 4 carboxamide (NSC 45388).
Cancer chemotherapy reports. Part 1.
58:753-754.
1974
|
|
